# First-in-Human Trial of Oral AN2-502998

> **NCT07024589** · PHASE1 · COMPLETED · sponsor: **AN2 Therapeutics, Inc** · enrollment: 72 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AN2-502998
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07024589
- **Lead sponsor:** AN2 Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-04
- **Primary completion:** 2026-03-14
- **Final completion:** 2026-03-14
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07024589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07024589, "First-in-Human Trial of Oral AN2-502998". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07024589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*